La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Kilitch Drugs (India) Bilan de santé
Santé financière contrôle des critères 3/6
Kilitch Drugs (India) possède un total de capitaux propres de ₹1.8B et une dette totale de ₹316.5M, ce qui porte son ratio d'endettement à 18%. Son actif total et son passif total sont ₹2.4B et de ₹643.9M. L'EBIT de Kilitch Drugs (India) est ₹162.2M ce qui fait que son ratio de couverture des intérêts 2.6. Elle dispose de liquidités et de placements à court terme de ₹690.7M.
Informations clés
18.0%
Ratio d'endettement
₹316.47m
Dette
| Ratio de couverture des intérêts | 2.6x |
| Argent liquide | ₹690.71m |
| Fonds propres | ₹1.76b |
| Total du passif | ₹643.88m |
| Total des actifs | ₹2.40b |
Mises à jour récentes de la santé financière
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05
These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03
Recent updates
Kilitch Drugs (India) Limited (NSE:KILITCH) Not Flying Under The Radar
Jul 23Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump
Feb 02We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease
Jan 30Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings
Nov 17Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why
Sep 23These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors
May 05Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today
Apr 08These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 13Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?
Aug 20Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 16Analyse de la situation financière
Passif à court terme: Les actifs à court terme de KILITCH ( ₹1.5B ) dépassent ses passifs à court terme ( ₹642.2M ).
Passif à long terme: Les actifs à court terme de KILITCH ( ₹1.5B ) dépassent ses passifs à long terme ( ₹1.7M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: KILITCH dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de KILITCH est passé de 7.7% à 18% au cours des 5 dernières années.
Couverture de la dette: Le flux de trésorerie opérationnel de KILITCH est négatif, par conséquent la dette n'est pas bien couverte.
Couverture des intérêts: Les paiements d'intérêts de KILITCH sur sa dette ne sont pas bien couverts par l'EBIT ( 2.6 x couverture).